A R T I C L E S
Lorance et al.
(ppm) ) 6.98 (d, 1 H, J ) 16.5 Hz), 7.25 (d, 1 H, J ) 16.5 Hz),
7.31-7.40 (m, 5 H), 7.51 (dd, 2 H, J ) 1.2, 8.1 Hz), 8.55 (d, 2 H, J
) 6.3 Hz). 13C NMR (75 MHz, CDCl3) δ (ppm) ) 120.8, 125.9, 126.9,
128.7, 128.8, 133.2, 136.1, 144.6, 150.0.
(d, 1 H), 9.19 (d, 1 H), 9.49 (d, 1 H). 13C NMR (75 MHz, CDCl3) δ
(ppm) ) 13.7, 52.8, 117.7, 121.5, 129.2, 129.6, 130.2, 135.2, 137.1,
146.4, 148.6. MS m/z 158.3 (M+).
N-Methoxyisoquinolinium Tetrafluoroborate (5). Following the
general procedure, trimethyloxonium tetrafluoroborate (4.48 g, 30.3
mmol) and isoquinoline N-oxide (4.00 g, 27.6 mmol) were stirred in
120 mL of dichloromethane for 4 h. Recrystallization from ethyl acetate
afforded 6.40 g (25.9 mmol, 94%) of 5. 1H NMR (300 MHz, CD3OD)
δ (ppm) ) 4.56 (s, 3 H), 8.06-8.11 (m, 1 H), 8.21-8.27 (m, 1 H),
8.34 (dd, 1 H, J ) 1.2, 8.1 Hz), 8.49 (dd, 1 H, J ) 1.2, 8.1 Hz), 8.57
(d, 1 H, J ) 7.2 Hz), 8.89-8.93 (m, 1 H), 10.20 (d, 1 H, J ) 1.8 Hz).
13C NMR (75 MHz, CD3OD) δ (ppm) ) 70.3, 118.5, 128.7, 129.0,
131.2, 132.3, 133.0, 138.1, 138.3, 145.5. MS m/z 160.6 (M+).
N-Ethylisoquinolinium Hexafluorophosphate (5E). Following the
general procedure, triethyloxonium hexafluorophosphate (5.81 g, 23.4
mmol) and isoquinoline (2.50 g, 19.4 mmol) were stirred in 60 mL of
dichloromethane for 4 h. Recrystallization from methanol/dichloro-
methane afforded 4.10 g (13.5 mmol, 70%) of 5E. 1H NMR (300 MHz,
CD3OD) δ (ppm) ) 1.71 (t, 3 H, J ) 7.2 Hz), 4.77 (q, 2 H, J ) 7.2
Hz), 8.00 (dt, 1 H, J ) 0.9, 8.1 Hz), 8.14-8.26 (m, 2 H), 8.39-8.46
(m, 2 H), 8.59 (dd, 1 H, J ) 0.9, 6.6 Hz), 9.78 (s, 1 H). 13C NMR (75
MHz, CD3OD) δ (ppm) ) 16.5, 58.3, 127.6, 128.4, 129.3, 131.5, 132.5,
135.3, 138.2, 138.9, 150.6. MS m/z 158.3 (M+).
N-Methoxyphenanthridinium Tetrafluoroborate (6). Following
the general procedure, trimethyloxonium tetrafluoroborate (1.42 g, 9.6
mmol) and phenanthridine N-oxide (1.7 g, 8.7 mmol) were stirred in
40 mL of dichloromethane for 4 h. Recrystallization from methanol
afforded 2.1 g (7.1 mmol, 81%) of 6. 1H NMR (500 MHz, CD3OD at
55 °C) δ (ppm) ) 4.67 (s, 3 H), 8.08-8.20 (m, 3 H), 8.38 (dt, 1 H, J
) 1.5, 7.8 Hz), 8.58 (dt, 2 H, J ) 1.0, 8.0 Hz), 9.02 (d, 1 H, J ) 8.5
Hz), 9.07 (d, 1 H, J ) 8.0 Hz), 10.46 (s, 1 H). 13C NMR (125 MHz,
CD3OD at 55 °C) δ (ppm) ) 70.3, 118.4, 124.5, 125.1, 125.9, 128.7,
131.9, 132.7, 133.2, 133.8, 133.9, 135.8, 139.6, 149.7. MS m/z 210.5
(M+).
4-(4-Nitrostyryl)pyridine. Following the literature procedure,32
4-picoline (3.08 g, 33.1 mmol) and 4-nitrobenzaldehyde (5.00 g, 33.1
mmol) were refluxed 12 h in 17 mL of acetic anhydride to give 4.32
g (19.1 mmol, 58%) of 4-(4-nitrostyryl)pyridine. Mp 166-168 °C. 1H
NMR (300 MHz, CDCl3) δ (ppm) ) 7.14 (d, 1 H, J ) 16.5 Hz), 7.31
(d, 1 H, J ) 16.5 Hz), 7.36-7.39 (m, 2 H), 7.63-7.66 (m, 2 H), 8.17-
8.21 (m, 2 H), 8.59 (br d, 2 H). 13C NMR (75 MHz, CDCl3) δ (ppm)
) 121.0, 124.1, 127.4, 130.3, 130.6, 142.4, 143.4, 147.4, 150.2.
4-(2,3,4,5,6-Pentafluorostyryl)pyridine. Following the literature
procedure,32 4-picoline (0.70 g, 7.65 mmol) and pentafluorobenzalde-
hyde (1.5 g, 7.65 mmol) were stirred 4 d in 15 mL of acetic anhydride.
The resulting solid was purified by column chromatography (silica gel,
methanol/dichloromethane 1:30, Rf ) 0.4) to give 0.5 g (1.84 mmol,
1
24%) of 4-(2,3,4,5,6-pentafluorostyryl)pyridine. Mp 113-115 °C. H
NMR (300 MHz, CDCl3) δ (ppm) ) 7.15 (d, 1 H, J ) 13.6 Hz), 7.33
(d, 1 H, J ) 13.6 Hz), 7.36 (d, 2 H, J ) 4.8 Hz), 8.61 (d, 2 H, J ) 4.0
Hz). 13C NMR (75 MHz, CDCl3) δ (ppm) ) 111.3, 117.2, 121.0, 134.4,
137.8, 140.5, 143.7, 145.0, 150.3. 19F NMR (470.9 MHz, CDCl3 (versus
NaF in D2O)) δ (ppm) ) -42.01 (dt, 2 F), -33.92 (t, 1 F), -21.59
(dd, 2 F). MS m/z 272.4 ((M + H)+).
N,N’-Dimethoxy-4,4’-dipyridylium Bis-tetrafluoroborate (2). Fol-
lowing the general procedure, trimethyloxonium tetrafluoroborate (847
mg, 5.70 mmol) and 4,4’-dipyridyl N,N’-dioxide (511 mg, 2.49 mmol)
were stirred in 10 mL of acetonitrile for 4 h. Recrystallization from
1
acetonitrile afforded 746 mg (1.90 mmol, 76%) of 2. H NMR (300
MHz, CD3OD(+CD3CN)) δ (ppm) ) 4.55 (s, 6 H), 8.60-8.64 (m, 4
H), 9.43-9.45 (m, 4 H). 13C NMR (75 MHz, CD3OD(+CD3CN)) δ
(ppm) ) 69.0, 116.6, 127.8, 141.0. MS m/z 187.2 ((M - OCH3)+).
N-Methoxy-4-cyanopyridinium Tetrafluoroborate (3). Following
the general procedure, trimethyloxonium tetrafluoroborate (0.72 g, 4.87
mmol) and 4-cyanopyridine N-oxide (0.56 g, 4.63 mmol) were stirred
in 30 mL of dichloromethane for 4 h. Recrystallization from methanol
afforded 0.81 g (3.65 mmol, 79%) of 3. 1H NMR (300 MHz, DMSO-
d6) δ (ppm) ) 4.48 (s, 3 H), 8.83 (d, 2 H, J ) 6.6 Hz), 9.75 (d, 2 H,
J ) 6.6 Hz). 13C NMR (75 MHz, DMSO-d6) δ (ppm) ) 69.7, 114.6,
126.1, 132.6, 142.2. MS m/z 135.3 (M+).
N-Ethylphenanthridinium Hexafluorophosphate (6E). Following
the general procedure, triethyloxonium hexafluorophosphate (3.10 g,
11.3 mmol) and phenanthridine (1.98 g, 11.0 mmol) were stirred in 25
mL of dichloromethane for 4 h. Recrystallization from chloroform/
1
acetonitrile afforded 4.10 g (13.5 mmol, 76%) of 6E. H NMR (500
MHz, DMSO-d6) δ (ppm) ) 1.71 (t, 3 H, J ) 7.2 Hz), 5.13 (q, 2 H,
J ) 7.2 Hz), 8.07-8.16 (m, 3 H), 8.38 (t, 1 H, J ) 7.2 Hz), 8.56 (d,
1 H, J ) 8.7 Hz), 8.62 (d, 1 H, J ) 8.1 Hz), 9.10 (d, 1 H, J ) 8.7 Hz),
9.13-9.17 (m, 1 H), 10.29 (s, 1 H). 13C NMR (125 MHz, DMSO-d6)
δ (ppm) ) 14.7, 53.3, 119.8, 123.0, 123.7, 124.9, 125.8, 130.2, 132.0,
132.7, 132.9, 134.2, 137.8, 155.1. MS m/z 208.3 (M+).
N-Ethyl-4-cyanopyridinium Hexafluorophosphate (3E). Following
the general procedure, triethyloxonium hexafluorophosphate (0.65 g,
2.62 mmol) and 4-cyanopyridine (0.24 g, 2.27 mmol) were stirred in
30 mL of dichloromethane for 4 h. Recrystallization from methanol/
1
dichloromethane afforded 0.36 g (1.29 mmol, 57%) of 3E. H NMR
(300 MHz, DMSO-d6) δ (ppm) ) 1.55 (t, 3 H, J ) 7.2 Hz), 4.68 (q,
2 H, J ) 7.2 Hz), 8.69 (d, 2 H, J ) 6.6 Hz), 9.35 (d, 2 H, J ) 6.6 Hz).
13C NMR (75 MHz, DMSO-d6) δ (ppm) ) 16.0, 57.5, 114.8, 126.9,
130.9, 146.0. MS m/z 133.2 (M+).
N-Methoxy-2-styrylpyridinium Tetrafluoroborate (7). Following
the general procedure, trimethyloxonium tetrafluoroborate (1.07 g, 7.30
mmol) and 2-styrylpyridine N-oxide (1.20 g, 6.08 mmol) were stirred
in 30 mL of dichloromethane for 4 h. Recrystallization from methanol
afforded 1.35 g (4.51 mmol, 74%) of 7. 1H NMR (300 MHz, CD3OD
(+CD3CN)) δ (ppm) ) 4.40 (s, 3 H), 7.49-7.52 (m, 3 H), 7.59 (d, 1
H, J ) 14.4 Hz), 7.81-7.85 (m, 2 H), 7.91 (dt, 1 H, J ) 1.5, 7.2 Hz),
8.06 (d, 1 H, J ) 14.4 Hz), 8.44 (dt, 1 H, J ) 1.8, 7.2 Hz,), 8.53 (dd,
1 H, J ) 1.8, 8.4 Hz), 9.03 (dd, 1 H, J ) 1.5, 6.6 Hz). 13C NMR (75
MHz, CD3OD (+CD3CN)) δ (ppm) ) 70.1, 113.9, 126.9, 127.6, 129.8,
130.3, 132.5, 135.8, 141.7, 145.0, 146.7, 151.6. MS m/z 212.6 (M+).
N-Ethyl-2-styrylpyridinium Hexafluorophosphate (7E). Following
the general procedure, triethyloxonium hexafluorophosphate (2.46 g,
9.93 mmol) and 2-styrylpyridine (1.50 g, 8.28 mmol) were stirred in
40 mL of dichloromethane for 4 h. Recrystallization from methanol/
N-Methoxyquinolinium Tetrafluoroborate (4). Following the
general procedure, trimethyloxonium tetrafluoroborate (4.09 g, 27.7
mmol) and quinoline N-oxide (3.65 g, 25.1 mmol) were stirred in 110
mL of dichloromethane for 4 h. Recrystallization from methanol/
1
dichloromethane afforded 3.80 g (15.4 mmol, 61%) of 4. H NMR
(300 MHz, CD3OD) δ (ppm) ) 4.60 (s, 3 H), 8.07-8.18 (m, 2 H),
8.34 (t, 1 H, J ) 7.8 Hz), 8.48 (d, 1 H, J ) 8.1 Hz), 8.59 (d, 1 H, J
) 8.7 Hz), 9.23 (d, 1 H, J ) 8.1 Hz), 9.76 (d, 1 H, J ) 6.6 Hz). 13C
NMR (75 MHz, CD3OD) δ (ppm) ) 70.5, 117.3, 123.3, 131.5, 132.3,
132.7, 137.7, 138.2, 145.1, 148.0. MS m/z 160.3 (M+).
N-Ethylquinolinium Hexafluorophosphate (4E). Following the
general procedure, triethyloxonium hexafluorophosphate (9.30 g, 37.0
mmol) and quinoline (4.00 g, 31.0 mmol) were stirred in 60 mL of
dichloromethane for 4 h. Recrystallization from methanol/dichloro-
methane afforded 6.62 g (21.8 mmol, 70%) of 4E. 1H NMR (300 MHz,
CDCl3) δ (ppm) ) 1.73 (t, 3 H, J ) 7.2 Hz), 5.15 (q, 2 H, J ) 7.2
Hz), 7.99 (dd, 1 H), 8.10 (dd, 1 H), 8.26 (dt, 1 H), 8.40 (d, 1 H), 8.56
1
dichloromethane afforded 1.90 g (12.4 mmol, 65%) of 7E. H NMR
(300 MHz, CD3CN) δ (ppm) ) 1.59 (t, 3 H, J ) 7.8 Hz), 4.75 (q, 2
H, J ) 7.8 Hz), 7.45-7.52 (m, 4 H), 7.78-7.88 (m, 4 H), 8.35-8.46
(m, 2 H), 8.73 (d, 1 H, J ) 6 Hz). 13C NMR (75 MHz, CD3CN) δ
(ppm) ) 15.8, 55.1, 117.7, 126.9, 127.4, 129.6, 130.2, 132.0, 136.0,
145.5, 145.8, 145.9, 153.9. MS m/z 210.3 (M+).
9
15236 J. AM. CHEM. SOC. VOL. 124, NO. 51, 2002